Yu‐Ning Wong
Philadelphia VA Medical Center · 223 works · 13,441 citations · h-index 52
Top works
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
- Time to Surgery and Breast Cancer Survival in the United States
- Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
- Survival Associated With Treatment vs Observation of Localized Prostate Cancer in Elderly Men
- Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work
- Clinicopathologic features, patterns of recurrence, and survival among women with triple‐negative breast cancer in the National Comprehensive Cancer Network
- Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors
- Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer
- Evaluating Overall Survival and Competing Risks of Death in Patients With Localized Renal Cell Carcinoma Using a Comprehensive Nomogram
- Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials
- Impact on overall survival (OS) with chemohormonal therapy versus hormonal therapy for hormone-sensitive newly metastatic prostate cancer (mPrCa): An ECOG-led phase III randomized trial.
- Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival
- Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity
- Trends in radical prostatectomy: centralization, robotics, and access to urologic cancer care
- Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial
- Positive Experience with Medical Savings Accounts in Singapore
- Age, Tumor Size and Relative Survival of Patients With Localized Renal Cell Carcinoma: A Surveillance, Epidemiology and End Results Analysis
- Preoperative Delays in the US Medicare Population With Breast Cancer
- Time to Adjuvant Chemotherapy for Breast Cancer in National Comprehensive Cancer Network Institutions
- Adoption of Gene Expression Profile Testing and Association With Use of Chemotherapy Among Women With Breast Cancer